Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Liver Int. 2013 Nov 24;34(8):1250–1258. doi: 10.1111/liv.12379

Table 4.

Univariate Analyses for Risk of Advanced Fibrosis (≤ Stage 2 vs. > Stage 2)

Odds Ratio 95% CI p
Age, years 1.06 [1.04–1.07] <0.0001
Male 0.68 [0.49–0.97] 0.03
Latino 0.42 [0.23–0.78] 0.006
Race 1.03 [0.91–1.18] 0.6
BMI, kg/m2 1.02 [1.00–1.05] 0.08
Waist, cm 1.02 [1.004–1.03] 0.006
Biopsy length, mm 1.03 [1.01–1.04] <0.0001
Coffee, cpd 1.10 [0.96–1.24] 0.2
AST, IU/L 1.009 [1.004–1.012] <0.0001
ALT, IU/L 0.99 [0.99–1.00] 0.4
Alk Phos, IU/L 1.01 [1.01–1.02]] <0.0001
Total Bili, mg/dL 1.09 [0.73–1.61] 0.7
GGT (IU/L) 1.004 [1.002–1.006] <0.0001
Glucose, (mg/dL) 1.01 [1.00–1.01] 0.004
Insulin, (μIU/mL) 1.02 [1.01–1.03] <0.0001
HOMA-IR 1.06 [1.03–1.09] <0.0001
Diabetes 2.66 [1.87–3.78] <0.0001
Hyperlipidemia 1.07 [0.77–1.47] 0.7
Alcohol, drinks/month 0.98 [0.96–0.99] 0.02
Smoking, ≥10 pack-years 2.01 [1.40–2.89] <0.0001
Physical Activity, METS/week 0.995 [0.992–0.998] 0.007
Education Level 0.61 [0.57–0.92] 0.006
Annual Income 0.74 [0.61–0.91] 0.003